Abiopharma

News list

Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE)

SEC News
Aug. 05, 2025, 20:07 UTC

New Form 10-Q - Spyre Therapeutics, Inc. Filed: 2025-08-05 AccNo: 0001636282-25-000089 Size: 9 MB

Full text

Register to leave comments
There are no comments here yet...